Lexaria Bioscience Corp. (LEXX)

Lexaria Bioscience Revenue

In the fiscal year ending August 31, 2024, Lexaria Bioscience had annual revenue of $464.28K with 105.24% growth. Lexaria Bioscience had revenue of $84.00K in the quarter ending August 31, 2024, with 173.25% growth.

• Revenue (ttm): $464.28K
• Revenue Growth: +105.24%
• P/S Ratio: 59.48
• Revenue / Employee: $66,325
• Employees: 7
• Market Cap: 38.92M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Aug 31, 2024	464.28K	238.07K	105.24%
Aug 31, 2023	226.21K	-29.19K	-11.43%
Aug 31, 2022	255.40K	-467.34K	-64.66%
Aug 31, 2021	722.74K	407.95K	129.59%
Aug 31, 2020	314.79K	92.18K	41.41%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.